R&D, Pharmacovigilance & Regulatory Affairs_uk

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

Title Location Date Sort descending Req ID
Reset
Regulatory Affairs Specialist
Regulatory Affairs Specialist Zaventem, BE 25 Mar 2026 7089
Zaventem, BE 25 Mar 2026 7089
Clinical Research Physician, Rare Disease
Clinical Research Physician, Rare Disease Europe - remote, IT 23 Mar 2026 7087
Europe - remote, IT 23 Mar 2026 7087
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT 20 Mar 2026 6955
Europe, IT 20 Mar 2026 6955
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 17 Mar 2026 6111
Senior Director, Clinical Biometrics & Analytics Parma, IT 13 Mar 2026 6387
Clinical Program Leader
Clinical Program Leader Cary, NC, US 13 Mar 2026 7017
Cary, NC, US 13 Mar 2026 7017
Master's thesis in computational modelling of aerosol deposition in respiratory system Parma, IT 13 Mar 2026 6598
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 11 Mar 2026 6592
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 7 Mar 2026 351
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 27 Feb 2026 5993
PARMA, IT 27 Feb 2026 5993